{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:44:56Z","timestamp":1791571496001,"version":"4.3.4"},"reference-count":164,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007234","name":"The University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015602","name":"Kovler Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.fertnstert.2022.03.020","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T21:15:23Z","timestamp":1651785323000},"page":"897-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4428-1636","authenticated-orcid":false,"given":"Iliana","family":"Doycheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2022.03.020_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30946","article-title":"The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis caused by NASH","volume":"70","author":"Loomba","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib8","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib13","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jgh3.12512","article-title":"Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"5","author":"Shengir","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib22","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib25","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib28","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/db16-1147","article-title":"Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver","volume":"66","author":"Jelenik","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib29","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib30","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, microbes, and polycystic ovary syndrome","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245219","article-title":"Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome","volume":"16","author":"Jobira","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0035-1562947","article-title":"The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2","volume":"35","author":"Anstee","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100501","article-title":"O-14 A synergistic effect of PNPLA3 gene polymorphism and insulin resistance increases the risk to non-alcoholic fatty liver disease in patients with polycystic ovary syndrome [Abstract]","volume":"24","author":"Recuero","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib40","first-page":"725","article-title":"The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS","volume":"11","author":"Qu","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib41","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.aohep.2020.01.004","article-title":"Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population","volume":"19","author":"Salva-Pastor","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","article-title":"Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome","volume":"41","author":"Oguz","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib46","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.cgh.2020.09.045","article-title":"Testosterone is associated with nonalcoholic steatohepatitis and fibrosis in premenopausal women with NAFLD","volume":"19","author":"Sarkar","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/ijpvm.IJPVM_305_16","article-title":"Nonalcoholic fatty liver disease in a sample of\u00a0Iranian women with polycystic ovary syndrome","volume":"8","author":"Mehrabian","year":"2017","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.dsx.2018.12.020","article-title":"Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"13","author":"Harsha Varma","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib52","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib53","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib54","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/hep.29068","article-title":"Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic","volume":"65","author":"Doycheva","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib55","article-title":"Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction","volume":"17","author":"Radulescu","year":"2021","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib56","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/hep4.1760","article-title":"Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007-2016","volume":"5","author":"Arshad","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib57","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/oby.21651","article-title":"Hepatic steatosis is common in adolescents with obesity and PCOS and relates to de novo lipogenesis but not insulin resistance","volume":"24","author":"Cree-Green","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib58","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jgh.13241","article-title":"Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys","volume":"31","author":"Ayonrinde","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cen.14062","article-title":"Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index)","volume":"91","author":"Carreau","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib60","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib62","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/00365521.2010.539251","article-title":"Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)","volume":"46","author":"Hossain","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib64","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib66","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib67","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib68","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib69","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1038\/s41598-021-86697-y","article-title":"Non-alcoholic fatty liver disease in polycystic ovary syndrome women","volume":"11","author":"Won","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib70","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","article-title":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome","volume":"60","author":"Sam","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib72","doi-asserted-by":"crossref","first-page":"104799","DOI":"10.1016\/j.phrs.2020.104799","volume":"159","author":"Jalali","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2265.2011.04093.x","article-title":"Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome","volume":"75","author":"Gangale","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib74","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821989238","article-title":"The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence","volume":"12","author":"Abdalla","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib76","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib77","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/clinem\/dgaa337","article-title":"Insulin sensitizers for improving the endocrine and metabolic profile in overweight women with PCOS","volume":"105","author":"Xing","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib78","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026295","article-title":"The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: a protocol for systematic review and meta-analysis","volume":"100","author":"Ma","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/cen.12369","article-title":"Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"81","author":"Kahal","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib81","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1164\/ajrccm.165.5.2201001b","article-title":"Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor?","volume":"165","author":"Tasali","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib82","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1152\/japplphysiol.00660.2005","article-title":"Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes","volume":"99","author":"Spiegel","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib83","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","article-title":"Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite","volume":"141","author":"Spiegel","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib85","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jc.2005-1084","article-title":"Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome","volume":"91","author":"Tasali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","article-title":"Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults","volume":"5","author":"Epstein","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib89","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib90","first-page":"1175","article-title":"Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome","volume":"86","author":"Fogel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib91","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2008-0925","article-title":"Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome","volume":"93","author":"Tasali","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib92","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.sleep.2014.06.023","article-title":"Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome","volume":"15","author":"Chatterjee","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib93","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/EC-17-0129","article-title":"Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature","volume":"6","author":"Helvaci","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.sleep.2016.12.029","article-title":"Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome: a nationwide longitudinal follow-up study","volume":"36","author":"Lin","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097041","article-title":"Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study","volume":"9","author":"Hung","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-18-0693","article-title":"Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study","volume":"180","author":"Kumarendran","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11325-019-01835-1","article-title":"The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Kahal","year":"2020","journal-title":"Sleep Breath"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib98","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","article-title":"The occurrence of sleep-disordered breathing among middle-aged adults","volume":"328","author":"Young","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/smrv.2002.0260","article-title":"Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms","volume":"7","author":"Jordan","year":"2003","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib100","first-page":"499","article-title":"Gender and obstructive sleep apnea syndrome, part 2: mechanisms","volume":"25","author":"Kapsimalis","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib101","first-page":"412","article-title":"Gender and obstructive sleep apnea syndrome, part 1: clinical features","volume":"25","author":"Kapsimalis","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib102","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1164\/ajrccm.161.5.9904121","article-title":"Gender differences in the polysomnographic features of obstructive sleep apnea","volume":"161","author":"O\u2019Connor","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib103","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1152\/jappl.1985.59.5.1452","article-title":"Influence of testosterone on ventilation and chemosensitivity in male subjects","volume":"59","author":"White","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib104","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1164\/ajrccm.149.2.8306057","article-title":"Effect of testosterone administration on upper airway collapsibility during sleep","volume":"149","author":"Cistulli","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/japplphysiol.00264.2002","article-title":"Effect of testosterone on the apneic threshold in women during NREM sleep","volume":"94","author":"Zhou","year":"2003","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fendo.2018.00377","article-title":"Determinants of slow-wave activity in overweight and obese adults: roles of sex, obstructive sleep apnea and testosterone levels","volume":"9","author":"Morselli","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib107","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy085","article-title":"The association between obstructive sleep apnea and metabolic abnormalities in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"41","author":"Kahal","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib108","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1164\/arrd.1986.133.1.38","article-title":"Breathing during sleep in normal pregnant women","volume":"133","author":"Brownell","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib109","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1378\/chest.120.5.1448","article-title":"Sleep-related disordered breathing during pregnancy in obese women","volume":"120","author":"Maasilta","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/sleep\/28.4.449","article-title":"The influence of the menstrual cycle on upper airway resistance and breathing during sleep","volume":"28","author":"Driver","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11325-003-0025-8","article-title":"Women with sleep apnea have lower levels of sex hormones","volume":"7","author":"Netzer","year":"2003","journal-title":"Sleep Breath"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib112","first-page":"68","article-title":"Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy","volume":"102","author":"Polo-Kantola","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib113","first-page":"391","article-title":"Sleep quality, estradiol levels, and behavioral factors in late reproductive age women","volume":"98","author":"Hollander","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib114","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1152\/jappl.1989.66.2.808","article-title":"Combined effects of female hormones and metabolic rate on ventilatory drives in women","volume":"66","author":"Regensteiner","year":"1989","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/sleep\/27.7.1405","article-title":"Sleep disorders during pregnancy","volume":"27","author":"Pien","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib116","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1152\/jappl.1998.84.3.1055","article-title":"Upper airway muscle activity in normal women: influence of hormonal status","volume":"84","author":"Popovic","year":"1998","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib117","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","article-title":"The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome","volume":"12","author":"Blank","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib118","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.1995.tb00543.x","article-title":"Spontaneous follicular and luteal function in infertile women with oligomenorrhoea: role of luteinizing hormone","volume":"43","author":"Fleming","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib119","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/humrep\/17.6.1459","article-title":"Luteal phase progesterone excretion in ovulatory women with polycystic ovaries","volume":"17","author":"Joseph-Horne","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0300-483X(01)00437-1","article-title":"Comparison of an array of in\u00a0vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens","volume":"166","author":"Gutendorf","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib121","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib122","series-title":"Chapter 4. The synthesis and metabolism of steroid hormones","author":"Strauss","year":"2004"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2796.1997.63889000.x","article-title":"Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects","volume":"241","author":"Shinohara","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib124","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/aje\/154.1.50","article-title":"Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study","volume":"154","author":"Newman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1183\/09031936.93.05040377","article-title":"Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea","volume":"5","author":"Hoffstein","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib126","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2004-1056","article-title":"On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders","volume":"90","author":"Buckley","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib127","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0006-3223(91)90093-2","article-title":"Sleep disruption alters nocturnal ACTH and cortisol secretory patterns","volume":"29","author":"Spath-Schwalbe","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib128","first-page":"865","article-title":"Sleep loss results in an elevation of cortisol levels the next evening","volume":"20","author":"Leproult","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07435800500456895","article-title":"Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients","volume":"31","author":"Parlapiano","year":"2005","journal-title":"Endocr Res"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2265.2004.01938.x","article-title":"Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function","volume":"60","author":"Lanfranco","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib131","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.13808","article-title":"Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS","volume":"89","author":"Shorakae","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib132","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12803","article-title":"Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance","volume":"83","author":"Lambert","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib133","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.rbmo.2017.03.018","article-title":"Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"35","author":"Gui","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib134","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","author":"Tasali","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/cs0920285","article-title":"Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man","volume":"92","author":"Grassi","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib136","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004872-199917060-00001","article-title":"How to assess sympathetic activity in humans","volume":"17","author":"Grassi","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib137","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1469-7793.2001.0861h.x","article-title":"Two sites for modulation of human sympathetic activity by arterial baroreceptors?","volume":"531","author":"Kienbaum","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib138","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1113\/jphysiol.1977.sp012050","article-title":"The variability of muscle nerve sympathetic activity in resting recumbent man","volume":"272","author":"Sundlof","year":"1977","journal-title":"J Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib139","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1113\/jphysiol.1992.sp019217","article-title":"Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans","volume":"453","author":"Wallin","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1113\/jphysiol.1996.sp021265","article-title":"Renal noradrenaline spillover correlates with muscle sympathetic activity in humans","volume":"491","author":"Wallin","year":"1996","journal-title":"J Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib141","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","article-title":"Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?","volume":"294","author":"Sverrisdottir","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib142","doi-asserted-by":"crossref","first-page":"R387","DOI":"10.1152\/ajpregu.00197.2009","article-title":"Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome","volume":"297","author":"Stener-Victorin","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib143","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/ajrccm.163.3.9911064","article-title":"Prevalence of sleep-disordered breathing in women: effects of gender","volume":"163","author":"Bixler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib144","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.CIR.98.11.1071","article-title":"Altered cardiovascular variability in obstructive sleep apnea","volume":"98","author":"Narkiewicz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib145","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/oxfordjournals.aje.a009572","article-title":"Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group","volume":"148","author":"Trevisan","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib146","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib147","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib148","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.41.6.715","article-title":"Prospective analysis of the insulin-resistance syndrome (syndrome X)","volume":"41","author":"Haffner","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib149","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.atherosclerosis.2003.12.022","article-title":"The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study","volume":"173","author":"Ford","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib150","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib152","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib153","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib154","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib156","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib157","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib158","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib159","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib161","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","article-title":"Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters","volume":"54","author":"Pirwany","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib162","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1210\/jc.2003-030044","article-title":"Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone","volume":"88","author":"Legro","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2022.03.020_bib164","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11325-021-02376-2","article-title":"Analysis of the proportion and clinical characteristics of obstructive sleep apnea in women with polycystic ovary syndrome","volume":"26","author":"Yang","year":"2022","journal-title":"Sleep Breath"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:16:15Z","timestamp":1762150575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028222002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":164,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0015028222002102"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.020","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92022 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}